Explore evidence

6.32 aORHigh adjusted odds of mortality were found among critically ill patients with leukemia (aOR 6.32).

Kenyaleukemiaobserved 2015–2017published 2020PloS onePubMeddocument of 5 observations

5 %5% of post-SPE CMD screens resulted in referral.

Kenyacommon mental disorderspublished 2023Frontiers in public healthPubMeddocument of 9 observations

9 casesAs of 30 September 2024, Kenya reported a cumulative total of 9 confirmed mpox cases.

Kenyampoxobserved 30 September 2024Africa CDCdocument of 147 observations

5.9 %Mycobacterium tuberculosis accounted for 5.9% (95% credible interval 3.9–8.3) of the aetiology of severe pneumonia in children aged 1–59 months without HIV infection and with positive chest x-rays.

Kenyapneumonieobserved Aug 15, 2011 to Jan 30, 2014published 2019Lancet (London, England)europe_pmcdocument of 9 observations

5 %C. dubliniensis (5%, n=2) was one of the predominant non-albicans Candida species.

KenyaC. dubliniensispublished 2022The Pan African medical journalPubMeddocument of 9 observations

39.8 hoursIn scenario 1, the average turnaround time (TAT) for HIV viral load monitoring was 39.8 hours.

KenyaVIH/sidapublished 2024Health policy and planningPubMeddocument of 15 observations

90 %Among smear-positive pulmonary tuberculosis/HIV co-infected patients in Kenya between 2012 and 2015, 90% had a treatment outcome of cured.

Kenyatuberculose · VIH/sidaobserved 2012-2015published 2020PloS onePubMeddocument of 6 observations

0 %The reported seroprevalence to Pfs48/45 varied from 0 to 64% across studies.

Kenyapaludismepublished 2019Frontiers in immunologyeurope_pmcdocument of 3 observations

0.44 hazard_ratioThere was no significant difference in risk of malaria between HIV-exposed, uninfected (CHEU) and HIV-unexposed, uninfected (CHUU) infants, with a hazard ratio of 0.44 (95% CI 0.16 to 1.21).

Kenyapaludismepublished 2025BMJ global healthPubMeddocument of 10 observations

24.7 %In Kilifi, seroprevalence of anti-SARS-CoV-2 IgG was 24.7% (95% CI 17.5–32.6%) at the end of the study period.

KenyaCOVID-19published 2022PLOS global public healtheurope_pmcdocument of 7 observationsDOI 10.1371/journal.pgph.0000883

90 %Fosfomycin was highly active against invasive Gram-negative isolates, including 90% (202/224) of Enterobacteriaceae and 96% (22/23) of Pseudomonas spp.

KenyaGram-negative bacteraemiapublished 2019Journal of medical microbiologyeurope_pmcdocument of 5 observations

10.1 %From May 2018 to March 2020, 772 out of 7614 male partners named by 2534 female index clients tested positive for HIV, representing a positivity rate of 10.1%.

KenyaVIH/sidaobserved May 2018 to March 2020published 2025Sexually transmitted diseasesPubMeddocument of 9 observations

3,556 admissions3556 malaria admissions were recorded for the five sites.

Kenyapaludismepublished 1997Lancet (London, England)europe_pmcdocument of 11 observations

Most factors in Western and South-East Kenya recorded a high infection prevalence of both HIV and malaria.

Kenyapaludisme · VIH/sidapublished 2021BMJ global healtheurope_pmcdocument of 3 observations

25.8 %The proportion of patients linked back to treatment was 25.8% in clinics with electronic health records only.

KenyaVIH/sidaobserved between Sept 1, 2012 and Jan 31, 2014published 2021BMC medical informatics and decision makingPubMeddocument of 5 observations

704 casesIn a pooled cohort of 117,114 individuals with baseline HIV negative test results in rural Uganda and Kenya, 704 seroconverted within 3 years.

KenyaVIH/sidapublished 2021PloS onePubMeddocument of 16 observations

85.8 %The prevalence of quintuple mutations (at codons 51, 59, 108, 437 and 540) conferring total sulfadoxine-pyrimethamine resistance was 85.8% among Plasmodium falciparum parasites isolated from pregnant women in coastal Kenya between 2013 and 2015.

Kenyapaludismeobserved 2013 and 2015published 2020Malaria journalPubMeddocument of 8 observations

27.1 %The prevalence of pica among pregnant or postpartum women on Mfangano Island, Kenya, was 27.1% in 2012.

Kenyapicaobserved 2012published 2019International journal of environmental research and public healtheurope_pmcdocument of 6 observations

3 %NTS accounted for 7/230 (3%) of blood culture isolates in the urban site in Kenya from 2006 to 2009.

Kenyanon-Typhi Salmonellaobserved 2006-2009published 2012PloS oneeurope_pmcdocument of 9 observationsDOI 10.1371/journal.pone.0031237

2.42 hazard_ratioRight ventricular dysfunction was significantly associated with mortality in patients with moderate to severe pulmonary hypertension, with an adjusted hazard ratio of 2.42.

Kenyapulmonary hypertension · right ventricular dysfunctionpublished 2020Global heartPubMeddocument of 10 observations

77 %Most participants (77%) were willing to ask their sex partner(s) to self-test before having sex.

KenyaVIH/sidapublished 2023AIDS carePubMeddocument of 5 observations

4 %In west and central Africa, low sulfadoxine-pyrimethamine resistance was categorised as a prevalence of the dhps Lys540Glu mutation of 4% or higher.

Kenyapaludismepublished 2025The Lancet. Infectious diseaseseurope_pmcdocument of 13 observations

94 %A majority of surveyed PrEP clients (269 out of 285, or 94%) reported HIV risk.

KenyaVIH/sidapublished 2024Journal of the International Association of Providers of AIDS CarePubMeddocument of 5 observations

50 %In Kenya, nearly 50% of women diagnosed with cervical cancer are diagnosed late.

Kenyacancer du col de l'utéruspublished 2026BMC research notesPubMeddocument of 7 observations

33.3 %Offering structured PrEP and PEP choice including long-acting cabotegravir and enabling risk-informed use could reduce HIV incidence by a third over 10 years.

KenyaVIH/sidaobserved 10 yearspublished 2025The lancet. HIVPubMeddocument of 11 observations